申请人:Akzo Nobel N.V.
公开号:EP0467435A2
公开(公告)日:1992-01-22
The invention relates to a benzhydryl derivative having the formula
wherein each of the groups Ri, R2, and R3 represents one to four substituents independently selected from the group consisting of hydrogen, lower alkyl, halogen, and CF3, and at least one of the groups Ri, R2, and R3 is halogen or CF3;
R4 represents hydrogen or methyl;
n is 2, 3, or 4;
m is 1, 2, or 3; and
X represents O or S;
or its pharmaceutically acceptable salts.
The benzhydryl derivative of the invention can be used to treat patients who are suffering from diseases which are influenced by calmodulin.
本发明涉及一种具有以下式子的苯甲酰衍生物
其中每个基团 Ri、R2 和 R3 代表一至四个取代基,这些取代基独立地选自氢、低级烷基、卤素和 CF3 组成的组,且至少一个基团 Ri、R2 和 R3 是卤素或 CF3;
R4 代表氢或甲基;
n 是 2、3 或 4;
m 是 1、2 或 3;以及
X 代表 O 或 S;
或其药学上可接受的盐类。
本发明的苄基衍生物可用于治疗受钙调素影响的疾病患者。